Please use this identifier to cite or link to this item:
https://doi.org/10.3390/jcm9030623
DC Field | Value | |
---|---|---|
dc.title | Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review | |
dc.contributor.author | Pang, Junxiong | |
dc.contributor.author | Wang, Min Xian | |
dc.contributor.author | Ang, Ian Yi Han | |
dc.contributor.author | Tan, Sharon Hui Xuan | |
dc.contributor.author | Lewis, Ruth Frances | |
dc.contributor.author | Chen, Jacinta I-Pei | |
dc.contributor.author | Gutierrez, Ramona A | |
dc.contributor.author | Gwee, Sylvia Xiao Wei | |
dc.contributor.author | Chua, Pearleen Ee Yong | |
dc.contributor.author | Yang, Qian | |
dc.contributor.author | Ng, Xian Yi | |
dc.contributor.author | Yap, Rowena KS | |
dc.contributor.author | Tan, Hao Yi | |
dc.contributor.author | Teo, Yik Ying | |
dc.contributor.author | Tan, Chorh Chuan | |
dc.contributor.author | Cook, Alex R | |
dc.contributor.author | Yap, Jason Chin-Huat | |
dc.contributor.author | Hsu, Li Yang | |
dc.date.accessioned | 2020-06-03T03:58:03Z | |
dc.date.available | 2020-06-03T03:58:03Z | |
dc.date.issued | 2020-03-01 | |
dc.identifier.citation | Pang, Junxiong, Wang, Min Xian, Ang, Ian Yi Han, Tan, Sharon Hui Xuan, Lewis, Ruth Frances, Chen, Jacinta I-Pei, Gutierrez, Ramona A, Gwee, Sylvia Xiao Wei, Chua, Pearleen Ee Yong, Yang, Qian, Ng, Xian Yi, Yap, Rowena KS, Tan, Hao Yi, Teo, Yik Ying, Tan, Chorh Chuan, Cook, Alex R, Yap, Jason Chin-Huat, Hsu, Li Yang (2020-03-01). Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review. JOURNAL OF CLINICAL MEDICINE 9 (3). ScholarBank@NUS Repository. https://doi.org/10.3390/jcm9030623 | |
dc.identifier.issn | 20770383 | |
dc.identifier.issn | 20770383 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/169014 | |
dc.description.abstract | Rapid diagnostics, vaccines and therapeutics are important interventions for the management of the 2019 novel coronavirus (2019-nCoV) outbreak. It is timely to systematically review the potential of these interventions, including those for Middle East respiratory syndrome-Coronavirus (MERS-CoV) and severe acute respiratory syndrome (SARS)-CoV, to guide policymakers globally on their prioritization of resources for research and development. A systematic search was carried out in three major electronic databases (PubMed, Embase and Cochrane Library) to identify published studies in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Supplementary strategies through Google Search and personal communications were used. A total of 27 studies fulfilled the criteria for review. Several laboratory protocols for confirmation of suspected 2019-nCoV cases using real-time reverse transcription polymerase chain reaction (RT-PCR) have been published. A commercial RT-PCR kit developed by the Beijing Genomic Institute is currently widely used in China and likely in Asia. However, serological assays as well as point-of-care testing kits have not been developed but are likely in the near future. Several vaccine candidates are in the pipeline. The likely earliest Phase 1 vaccine trial is a synthetic DNA-based candidate. A number of novel compounds as well as therapeutics licensed for other conditions appear to have in vitro efficacy against the 2019-nCoV. Some are being tested in clinical trials against MERS-CoV and SARS-CoV, while others have been listed for clinical trials against 2019-nCoV. However, there are currently no effective specific antivirals or drug combinations supported by high-level evidence. | |
dc.language.iso | en | |
dc.publisher | MDPI | |
dc.source | Elements | |
dc.subject | Science & Technology | |
dc.subject | Life Sciences & Biomedicine | |
dc.subject | Medicine, General & Internal | |
dc.subject | General & Internal Medicine | |
dc.subject | novel coronavirus | |
dc.subject | diagnostics | |
dc.subject | vaccine | |
dc.subject | treatments | |
dc.subject | global health | |
dc.subject | outbreak | |
dc.subject | MERS-CoV | |
dc.subject | SARS-CoV | |
dc.subject | RESPIRATORY SYNDROME CORONAVIRUS | |
dc.subject | SARS-CORONAVIRUS | |
dc.subject | CLINICAL VALIDATION | |
dc.subject | PCR ASSAYS | |
dc.subject | MERS-COV | |
dc.subject | INFECTION | |
dc.subject | ANTIBODY | |
dc.subject | REPLICATION | |
dc.subject | INHIBITION | |
dc.subject | PNEUMONIA | |
dc.type | Review | |
dc.date.updated | 2020-05-27T13:27:59Z | |
dc.contributor.department | DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH) | |
dc.contributor.department | MEDICINE | |
dc.contributor.department | SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH | |
dc.description.doi | 10.3390/jcm9030623 | |
dc.description.sourcetitle | JOURNAL OF CLINICAL MEDICINE | |
dc.description.volume | 9 | |
dc.description.issue | 3 | |
dc.published.state | Published | |
Appears in Collections: | Staff Publications Elements |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV) A Systematic Review.pdf | Published version | 853.65 kB | Adobe PDF | OPEN | Published | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.